Clinuvel Pharmaceuticals Limited’s (CUV) Moving Averages Convergence Divergence (MACD) indicator is -0.26, suggesting Clinuvel Pharmaceuticals Limited is a Sell.

Clinuvel Pharmaceuticals Limited’s (CUV) 20-Day exponential moving average is 11.92, while Clinuvel Pharmaceuticals Limited’s (CUV) share price is AU$11.88, making it a Sell.

Clinuvel Pharmaceuticals Limited’s (CUV) 50-Day exponential moving average is 12.50, while Clinuvel Pharmaceuticals Limited’s (CUV) share price is AU$11.88, making it a Sell.

Clinuvel Pharmaceuticals Limited (CUV) Pivot Points

Jan 19, 2025, 07:34 AM

Classic

11.27

11.50

11.65

11.88

12.03

12.26

12.41

Fibonacci

11.50

11.65

11.74

11.88

12.03

12.12

12.26

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Clinuvel Pharmaceuticals Limited (CUV) Moving Averages

Jan 19, 2025, 07:34 AM

MA5

11.68Buy

11.76Buy

MA10

11.68Buy

11.76Buy

MA20

11.86Buy

11.92Sell

MA50

12.59Sell

12.50Sell

MA100

13.52Sell

13.16Sell

MA200

14.20Sell

13.86Sell

Clinuvel Pharmaceuticals Limited’s (CUV) 10-Day exponential moving average is 11.76, while Clinuvel Pharmaceuticals Limited’s (CUV) share price is AU$11.88, making it a Buy.

Clinuvel Pharmaceuticals Limited’s (CUV) 100-Day exponential moving average is 13.16, while Clinuvel Pharmaceuticals Limited’s (CUV) share price is AU$11.88, making it a Sell.

Clinuvel Pharmaceuticals Limited’s (CUV) stock price is AU$11.88 and Clinuvel Pharmaceuticals Limited’s (CUV) 50-day simple moving average is 12.59, creating a Sell signal.

Clinuvel Pharmaceuticals Limited’s (CUV) stock price is AU$11.88 and Clinuvel Pharmaceuticals Limited’s (CUV) 100-day simple moving average is 13.52, creating a Sell signal.

Clinuvel Pharmaceuticals Limited’s (CUV) stock price is AU$11.88 and Clinuvel Pharmaceuticals Limited’s (CUV) 200-day simple moving average is 14.20, creating a Sell signal.

Clinuvel Pharmaceuticals Limited (CUV) Technical Indicators

Jan 19, 2025, 07:34 AM

RSI (14)

45.93

Neutral

STOCH (9,6)

68.73

Neutral

STOCHRSI (14)

49.10

Neutral

MACD (12,26)

-0.26

Sell

ADX (14)

24.04

Neutral

Williams %R

-43.75

Buy

CCI (14)

6.78

Neutral

ATR (14)

0.37

Ultimate Oscillator

43.04

Neutral

ROC

-4.65

Sell

Clinuvel Pharmaceuticals Limited’s (CUV) Relative Strength Index (RSI) is 45.93, creating a Neutral signal.

Clinuvel Pharmaceuticals Limited’s (CUV) Trend Strength Indicator (ADX) is 24.04, creating a Neutral signal.

Clinuvel Pharmaceuticals Limited’s (CUV) Commodity Channel Index (CCI) is 6.78, creating a Neutral signal.

Clinuvel Pharmaceuticals Limited’s (CUV) Price Rate of Change (ROC) is -4.65, creating a Sell signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is CUV a Buy, Hold, or Sell?

Based on CUV’s technical indicators, CUV is a Hold.

What is CUV’s RSI (14)?

CUV’s RSI (14) is 45.93, which suggests CUV is a Neutral.

What is CUV’s MACD?

CUV’s MACD is -0.26, which suggests CUV is a Sell.

What is CUV’s 5-day moving average?

CUV’s 5-day moving average is 11.68, which suggests CUV is a Buy.

What is CUV’s 20-day moving average?

CUV 20-day moving average is 11.86, which suggests CUV is a Buy.

What is CUV’s 50-day moving average?

CUV’s 50-day moving average is 12.59, which suggests CUV is a Sell.

What is CUV’s 200-day moving average?

CUV’s 200-day moving average is 14.20, which suggests CUV is a Sell.

What is CUV’s Williams % R (14)?

CUV’s Williams % R (14) is -43.75, which suggests CUV is a Buy.

What is CUV’s CCI (14)?

CUV’s CCI (14) is 6.78, which suggests CUV is a Neutral.

What is the share price of Clinuvel Pharmaceuticals Limited?

Clinuvel Pharmaceuticals Limited's share price is N/AAU$.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing